ArticleFrontiers in immunology2019

Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.

Emma Persson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.